Alpha Tau Medical (DRTS) Operating Expenses (2021 - 2026)
Alpha Tau Medical (DRTS) posted Operating Expenses of $13.1 million for Q1 2026, up 7.59% sequentially from $12.1 million in Q4 2025, and up 47.72% YoY from $8.8 million in Q1 2025.
Alpha Tau Medical (DRTS) Operating Expenses (2021 - 2026) Analysis & Trends
Alpha Tau Medical has reported Operating Expenses for 6 years, with the latest figure at $13.1 million in Q1 2026.
- Quarterly Operating Expenses rose 47.72% year-over-year to $13.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $44.7 million (up 28.86% YoY) and the FY2025 annual result came in at -$5.0 million, down 3.02% from the prior year.
- Operating Expenses climbed to $13.1 million in Q1 2026 per DRTS's latest filing, from $12.1 million in the prior quarter.
- Over five years, Operating Expenses peaked at $13.1 million in Q1 2026 and troughed at $7.1 million in Q3 2022.
- A 5-year average of $8.9 million and a median of $8.5 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2024: Operating Expenses surged 233.84% in 2022, then decreased 7.31% in 2024.
- Over 5 years, Operating Expenses stood at $7.6 million in 2022, then grew by 25.08% to $9.5 million in 2023, then grew by 1.01% to $9.6 million in 2024, then grew by 26.73% to $12.1 million in 2025, then gained by 7.59% to $13.1 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $13.1 million, $12.1 million, and $10.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | 13.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.47 Mn |
| Mar 31, 2026 | 13.07 Mn |
| Dec 31, 2025 | 12.15 Mn |
| Sep 30, 2025 | 10.24 Mn |
| Jun 30, 2025 | 9.19 Mn |
| Mar 31, 2025 | 8.85 Mn |
| Dec 31, 2024 | 9.59 Mn |
| Sep 30, 2024 | 7.76 Mn |
| Jun 30, 2024 | 8.45 Mn |
| Mar 31, 2024 | 7.89 Mn |
| Dec 31, 2023 | 9.49 Mn |
| Sep 30, 2023 | 8.37 Mn |
| Jun 30, 2023 | 7.65 Mn |
| Mar 31, 2023 | 8.24 Mn |
| Dec 31, 2022 | 7.59 Mn |
| Sep 30, 2022 | 7.11 Mn |
| Jun 30, 2022 | 7.89 Mn |
| Mar 31, 2022 | 8.57 Mn |
| Dec 31, 2021 | 3.82 Mn |
| Sep 30, 2021 | 3.53 Mn |